Recent studies indicated that the activation of GPR30 can inhibit the proliferation of cancer cells via MAPK signals.10,16 We assayed the effects of GPR30 agonist G1 on phosphorylation of MAPK in ER− breast cancer cells. The gene discussed is GPER1; the disease is cancer.